Fused Deposition Modelling as a Potential Tool for Antimicrobial Dialysis Catheters Manufacturing: New Trends vs. Conventional Approaches
Source abstract
Abstract
The rising rate of individuals with chronic kidney disease (CKD) and ineffective treatment methods for catheter-associated infections in dialysis patients has led to the need for a novel approach to the manufacturing of catheters. The current process requires moulding, which is time consuming, and coated catheters used currently increase the risk of bacterial resistance, toxicity, and added expense. Three-dimensional (3D) printing has gained a lot of attention in recent years and offers the opportunity to rapidly manufacture catheters, matched to patients through imaging and at a lower cost. Fused deposition modelling (FDM) in particular allows thermoplastic polymers to be printed into the desired devices from a model made using computer aided design (CAD). Limitations to FDM include the small range of thermoplastic polymers that are compatible with this form of printing and the high degradation temperature required for drugs to be extruded with the polymer. Hot-melt extrusion (HME) allows the potential for antimicrobial drugs to be added to the polymer to create catheters with antimicrobial activity, therefore being able to overcome the issue of increased rates of infection. This review will cover the area of dialysis and catheter-related infections, current manufacturing processes of catheters and methods to prevent infection, limitations of current processes of catheter manufacture, future directions into the manufacture of catheters, and how drugs can be incorporated into the polymers to help prevent infection.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · biodegradable polymer synthesis and properties · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UK
References (87)
Show source-provided references
1. Kidney Care UK (2017). Patient Reported Experience of Kidney Care in England and Wales 2017, Kidney Care UK.
2. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases10.1038/ki.2011.368 ↗
3. Kidney Care UK (2019, March 07). Facts and Stats. Available online: https://www.kidneycareuk.org/news-and-campaigns/facts-and-stats/.
4. Kerr, M. (2012). Chronic Kidney Disease in England: The Human and Financial Cost, Insight Health Economics Ltd.
5. Lewis, R. (2011). Understanding Chronic Kidney Disease: A Guide for the Non-Specialist, M&K Update Ltd.
6. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016–40 for 195 countries and territories10.1016/S0140-6736(18)31694-5 ↗
7. (2019, March 07). Dialysis—NHS. Available online: https://www.nhs.uk/conditions/dialysis/.
8. Guidelines for the Prevention of Intravascular Catheter-related Infections: Recommendations Relevant to Interventional Radiology for Venous Catheter Placement and Maintenance10.1016/j.jvir.2012.04.023 ↗
9. Are antimicrobial peripherally inserted central catheters associated with reduction in central line—associated bloodstream infection? A systematic review and meta-analysis10.1016/j.ajic.2016.07.021 ↗
10. Non-Tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: A prospective cohort study10.1186/s12882-017-0760-x ↗
11. Precurved non-tunnelled catheters for haemodialysis are comparable in terms of infections and malfunction as compared to tunnelled catheters: A retrospective cohort study10.1177/1129729818805954 ↗
12. Water infused surface protection as an active mechanism for fibrin sheath prevention in central venous catheters10.1111/aor.12916 ↗
13. Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of gram-negative microorganisms from a 25-year prospective observational study10.1128/AAC.00892-18 ↗
14. Hemodialysis tunneled catheter noninfectious complications
15. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia10.1016/j.jinf.2013.04.018 ↗
16. Brass, P., Hellmich, M., Kolodziej, L., Schick, G., and Af, S. (2015). Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization. Cochrane Database Syst. Rev.10.1002/14651858.CD006962.pub2 ↗
17. Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: A systematic review and network meta-analysis10.1186/s13613-018-0416-4 ↗
18. Development of antibacterial quaternary ammonium silane coatings on polyurethane catheters10.1016/j.jcis.2015.04.007 ↗
19. What’s new: Prevention of acute dialysis catheter-related infection10.1007/s00134-017-4833-x ↗
20. Prevention of bacterial colonization on catheters by a one-step coating process involving an antibiofouling polymer in water10.1021/acsami.7b06899 ↗
21. Prevention and management of catheter-related infection in hemodialysis patients10.1038/ki.2010.471 ↗
22. Fibrin sheath of a peripherally inserted central catheter undepicted with gray-scale (real-time B-mode) ultrasonography: A case report10.1016/j.radcr.2018.02.016 ↗
23. Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia10.5301/jva.5000301 ↗
24. Fibrin sheath formation and intimal thickening after catheter placement in dog model: Role of hemodynamic wall shear stress10.5301/jva.5000358 ↗
25. TuLIP (Tunnelled Line Intraluminal Plasty): An alternative technique for salvaging haemodialysis catheter patency in fibrin sheath formation10.1007/s00270-019-02189-7 ↗
26. An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters10.1186/s40169-015-0050-9 ↗
27. (2019, August 14). UV-CURE SILICONES ENABLE NEW MEDICAL DEVICE DESIGN CONCEPTS AND INCREASE CUSTOMER VALUE. Available online: https://www.freudenbergmedical.com/ecomaXL/files/UV-Cure_Silicones.pdf?download=1.
28. Ventricular catheter development: Past, present, and future10.3171/2015.12.JNS151181 ↗
29. Chitosan/Poly (vinyl alcohol) blending hydrogel coating improves the surface characteristics of segmented polyurethane urethral catheters10.1002/jbm.b.30796 ↗
30. 3D printed antibiotic and chemotherapeutic eluting catheters for potential use in interventional radiology: In vitro proof of concept study10.1016/j.acra.2018.03.022 ↗
31. Surface characteristics and antimicrobial properties of modified catheter surfaces by polypyrogallol and metal ions10.1016/j.msec.2018.04.095 ↗
32. Falk, A. (2008). The Role of Surface Coatings on Central Venous and Hemodialysis Catheters. Endovasc. Today, 28–30.
33. Ps, S., and Shah, N. (2014). Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database Syst. Rev., 3–5.10.1002/14651858.CD005983.pub3 ↗
34. Nicolas, D.R.M. (2018). Heparin Induced Thrombocytopenia (HIT), StatPearls.
35. Outcomes after heparin-Induced thrombocytopenia in patients with propaten vascular grafts10.1016/j.avsg.2011.12.011 ↗
36. Silver nanoparticles as potential antibacterial agents10.3390/molecules20058856 ↗
37. Mechanisms of silver nanoparticle release, transformation and toxicity: A critical review of current knowledge and recommendations for future studies and applications10.3390/ma6062295 ↗
38. A ntimicrobial activity and cytocompatibility of silver nanoparticles coated catheters via a biomimetic surface functionalization strategy
39. Preventing implant-associated infections by silver coating10.1128/AAC.02934-15 ↗
40. Freitas, P.D. (2018). Incorporation of Silver Nanoparticles by the Irradiation Process in Central Venous Catheter (CVC) of Polyurethane Coated with Titanium Oxide for Antimicrobial Activity. [Master’s Thesis, Instituto de Pesquisas Energéticas e Nucleares].
41. Effectiveness of silver-impregnated central. venous catheters for preventing catheter-related blood stream infections: A meta-analysis10.1016/j.ijid.2014.09.018 ↗
42. Extracellular biosynthesis, characterization, optimization of silver nanoparticles (AgNPs) using Bacillus mojavensis BTCB15 and its antimicrobial activity against multidrug resistant pathogens10.1080/10826068.2018.1550654 ↗
43. baptiste Antimicrobial surface functionalization of plastic catheters by silver nanoparticles10.1093/jac/dkn034 ↗
44. Antimicrobial potency of differently coated 10 and 50 nm silver nanoparticles against clinically relevant bacteria Escherichia coli and Staphylococcus aureus10.1016/j.colsurfb.2018.06.027 ↗
45. Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli
46. The increasing use of silver-based products as antimicrobial agents: A useful development or a cause for concern?10.1093/jac/dkm006 ↗
47. Bacterial resistance to silver in wound care10.1016/j.jhin.2004.11.014 ↗
48. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds10.1016/S0168-6445(03)00047-0 ↗
49. Effects of silver nanoparticles on human health10.1515/ejnm-2014-0032 ↗
50. Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection10.1016/j.jconrel.2016.09.018 ↗
51. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection10.1111/tid.13017 ↗
52. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling10.1016/j.ijpharm.2016.05.036 ↗
53. Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications
54. Influence of surface properties on the adhesion of staphylococcus epidermidis to acrylic and silicone10.1155/2009/718017 ↗
55. Surface roughness of FDM parts after post-processing with acetone vapor bath smoothing process10.1007/s00170-017-1165-5 ↗
56. Pérez, M., Medina-Sánchez, G., García-Collado, A., Gupta, M., and Carou, D. (2018). Surface quality enhancement of fused deposition modeling (FDM) printed samples based on the selection of critical printing parameters. Materials, 11.10.3390/ma11081382 ↗
57. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration10.1016/j.ijpharm.2017.07.008 ↗
58. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding10.1016/j.ijpharm.2016.04.057 ↗
59. Patient-specific 3D scanned and 3D printed antimicrobial polycaprolactone wound dressings10.1016/j.ijpharm.2017.04.077 ↗
60. Tan, D.K., Maniruzzaman, M., and Nokhodchi, A. (2018). Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery. Pharmaceutics, 10.10.3390/pharmaceutics10040203 ↗
61. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing10.1016/j.ejpb.2016.08.016 ↗
62. Tappa, K., and Jammalamadaka, U. (2018). Novel biomaterials used in medical 3D printing techniques. J. Funct. Biomater., 9.10.3390/jfb9010017 ↗
63. Stewart, A.S., Domínguez-Robles, J., Donnelly, F.R., and Larrañeta, E. (2018). Implantable polymeric drug delivery devices: Classification, manufacture, materials, and clinical applications. Polymers, 10.10.3390/polym10121379 ↗
64. Domínguez-Robles, J., Martin, K.N., Fong, L.M., Stewart, A.S., Irwin, J.N., Rial-Hermida, I.M., Donnelly, F.R., and Larrañeta, E. (2019). Antioxidant PLA composites containing lignin for 3d printing applications: A potential material for healthcare applications. Pharmaceutics, 11.10.3390/pharmaceutics11040165 ↗
65. Biomedical applications of Poly (Lactic Acid)
66. Synthesis and characterisation of superparamagnetic polylactic acid based polymers
67. Jiménez, A., Peltzer, M., and Ruseckaite, R. (2014). PLA Synthesis and Polymerization. Poly(Lactic Acid) Science and Technology: Processing, Properties, Additives and Applications, Royal Society of Chemistry.10.1039/9781782624806 ↗
68. Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive review10.1016/j.addr.2016.06.012 ↗
69. FDM 3D printing of high-pressure, heat-resistant, transparent microfluidic devices10.1021/acs.analchem.8b02356 ↗
70. Guerra, A.J., Cano, P., Rabionet, M., Puig, T., and Ciurana, J. (2018). 3D-printed PCL/PLA composite stents: Towards a new solution to cardiovascular problems. Materials, 11.10.3390/ma11091679 ↗
71. PLA/F68/Dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study10.1016/j.ijpharm.2012.11.019 ↗
72. PLA/PEG-PPG-PEG/Dexamethasone implant prepared by hot-melt extrusion for controlled release of immunosuppressive drug to implantable medical devices, part 2: In vivo evaluation10.3109/10717544.2013.801049 ↗
73. 3D printed Polycaprolactone scaffolds with dual macro-microporosity for applications in local delivery of antibiotics10.1016/j.msec.2018.02.008 ↗
74. 3D printing of vaginal rings with personalized shapes for controlled release of progesterone10.1016/j.ijpharm.2018.01.036 ↗
75. Evaluation of a new PVC-free catheter material for intermittent catheterization: A prospective, randomized, crossover study10.3109/00365599.2012.696136 ↗
76. Investigations for mechanical properties of Hap, PVC and PP based 3D porous structures obtained through biocompatible FDM filaments10.1016/j.compositesb.2017.08.021 ↗
77. Poly(vinyl chloride) and poly(e-caprolactone) blends for medical use10.1177/0892705706056463 ↗
78. Modeling, design and manufacture of innovative floating gastroretentive drug delivery systems based on hot-melt extruded tubes10.1016/j.ejpb.2019.02.022 ↗
79. Haryńska, A., Gubanska, I., Kucinska-Lipka, J., and Janik, H. (2018). Fabrication and characterization of flexible medical-grade tpu filament for fused deposition modeling 3dp technology. Polymers, 10.10.20944/preprints201810.0552.v1 ↗
80. Synthesis and characterization of silicone polymer/functionalized mesostructured silica composites10.1039/c1py00316j ↗
81. (2018, August 14). Thermal Analysis of Silicone Rubber. Available online: https://www.hitachi-hightech.com/file/global/pdf/products/science/appli/ana/thermal/application_TA_018e.pdf.
82. The extrusion-based additive manufacturing of moisture-cured silicone elastomer with minimal void for pneumatic actuators
83. Hamidi, A., Jain, S., and Tadesse, Y. (2017, January 17). 3D printing PLA and silicone elastomer structures with sugar solution support material. Proceedings of the SPIE, Portland, OR, USA.10.1117/12.2258689 ↗
84. Urinary catheters: History, current status, adverse events and research agenda10.3109/03091902.2015.1085600 ↗
85. Formulation strategies for solid oral dosage form using 3D printing technology: A mini-review10.1016/j.jddst.2018.05.009 ↗
86. Regulatory interfaces surrounding the growing field of additive manufacturing of medical devices and biologic products10.1017/cts.2018.331 ↗
87. U.S. Food and Drug Administration (2017). Technical Considerations for Additive Manufactured Medical Devices. Guidance for Industry and Food and Drug Administration Staff.